In the article titled “A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements” [1], Reference [31] referred to a study using Vivomixx®. We have recently been made aware of a concern regarding the described composition of the Vivomixx® product, and the publishers of the study protocol [2] and results [3] have been informed. These articles may be subject to correction.
References
- 1.Sivamaruthi B. S., Kesika P., Suganthy N., Chaiyasut C. A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements. BioMed Research International . 2019;2019:20. doi: 10.1155/2019/3291367.3291367 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Halkjaer S. I., Nilas L., Carlsen E. M., et al. Effects of probiotics (Vivomixx®) in obese pregnant women and their newborn: study protocol for a randomized controlled trial. Trials . 2016;17(1):p. 491. doi: 10.1186/s13063-016-1617-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Halkjær S. I., de Knegt V. E., Lo B., et al. Multistrain Probiotic Increases the Gut Microbiota Diversity in Obese Pregnant Women: Results from a Randomized, Double-Blind Placebo-Controlled Study. Current Developments in Nutrition . 2020;4(7, article nzaa095) doi: 10.1093/cdn/nzaa095. [DOI] [PMC free article] [PubMed] [Google Scholar]